Literature DB >> 21126107

Untreated depressive symptoms among cognitively-intact, community dwelling Filipino patients with Parkinson disease.

Criscely L Go1, Raymond L Rosales, Michelle Joya-Tanglao, Hubert H Fernandez.   

Abstract

The objective of this study is to determine the prevalence of depressive symptoms and its correlation with the quality of life among cognitively intact, community dwelling Filipino patients with Parkinson disease (PD) not treated pharmacologically for depression. In this prospective, cross-sectional study 76 PD patients were included. Demographic data were obtained including: age, gender, onset of disease, disease duration, and medication intake. The Mini Mental State Examination (MMSE) was performed to exclude significant cognitive impairment. The Montgomery Asberg Depression Rating Scale (MADRS) was administered to quantify the degree of depressive symptoms. The degree of depressive symptoms was correlated with the SF 36 and UPDRS Parts II and III. Our cohort of patients had a mean age of 61 years (range: 42-81 years), and disease duration of 2.7 years (33 months); 46 (61%) experienced significant depressive symptoms based on the MADRS cutoff score of >14. Depressive symptoms were associated with poorer performance on both UPDRS Parts II and III and SF 36. Untreated depressive symptoms among Filipinos with PD may be higher compared to other PD populations but prospective and age-matched controlled studies will need to be performed to confirm these preliminary observations. The presence of depressive symptoms was significantly correlated with poorer quality of life and level of functioning.

Entities:  

Mesh:

Year:  2010        PMID: 21126107     DOI: 10.3109/00207454.2010.537414

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  3 in total

1.  A community-based validation study of the short-form 36 version 2 Philippines (Tagalog) in two cities in the Philippines.

Authors:  Nina T Castillo-Carandang; Olivia T Sison; Mary Lenore Grefal; Rody G Sy; Oliver C Alix; Elmer Jasper B Llanes; Paul Ferdinand M Reganit; Allan Wilbert G Gumatay; Felix Eduardo R Punzalan; Felicidad V Velandria; E Shyong Tai; Hwee-Lin Wee
Journal:  PLoS One       Date:  2013-12-26       Impact factor: 3.240

2.  Major depressive disorder in Parkinson's disease: a cross-sectional study from Sri Lanka.

Authors:  Tharini Ketharanathan; Raveen Hanwella; Rajiv Weerasundera; Varuni A de Silva
Journal:  BMC Psychiatry       Date:  2014-09-30       Impact factor: 3.630

3.  Dopaminergic dysregulation, artistic expressiveness, and Parkinson's disease.

Authors:  S López-Pousa; C Lombardía-Fernández; J Garre Olmo; S Monserrat-Vila; J Vilalta-Franch; L Calvó-Perxas
Journal:  Case Rep Neurol       Date:  2012-11-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.